ContextDespite widespread use of serum prostate-specific antigen (PSA) testing to detect
prostate cancer, the relative effectiveness of different PSA screening strategies is unknown …

Objective.—To determine for the first 4 years of serial prostate-specific antigen (PSA)-based
screening trends in compliance, prevalence of abnormal screening test results, cancer …

Background Although there is uncertainty about the effect of prostate-specific antigen (PSA)
screening on the rate of prostate cancer death, there is little uncertainty about its effect on …

Abstract Background Studies conducted in Swedish populations have shown that men with
lowest prostate-specific antigen (PSA) levels at ages 44–50 years and 60 years have very …

Chinese translation Background: The US Preventive Services Task Force recently
concluded that the harms of existing prostate-specific antigen (PSA) screening strategies …

Importance Prostate cancer screening with the prostate-specific antigen (PSA) test remains
controversial. Objective To review evidence from randomized trials and related modeling …

Background: The finding that some men with a normal prostate-specific antigen (PSA) level
(ie, less than 4 ng/mL) nonetheless have microscopic evidence of prostate cancer has led to …

Objective.—To assess the reasons for the dramatic surge in prostate cancer incidence from
1986 to 1991. Design.—Population-based study of incidence rates and procedures used to …

BACKGROUND Prostate‐specific antigen (PSA) screening for prostate cancer has high risks
of overdiagnosis, particularly among older men, and reports from screening trials indicate …

Objective To quantify the plausible contribution of prostate-specific antigen (PSA) screening
to the nearly 30% decline in the US prostate cancer mortality rate observed during the …